Time-based but not event-based prospective memory remains impaired one year after the onset of schizophrenia: A prospective study.

Abstract:

BACKGROUND:Prospective memory (PM) deficits have been consistently found in people with schizophrenia. Although there is evidence to suggest that PM deficits may be putative markers for schizophrenia, no longitudinal study has investigated the persistence of PM deficits. AIMS:We examined whether PM deficits persist after the onset of schizophrenia, and compared the trajectories of time- and event-based PM performance 12 months after illness onset. We also examined whether the association between PM and clinical symptoms changes over time 12 months after illness onset. METHOD:We recruited 58 individuals with first-episode schizophrenia for a 12-month follow-up study. Comparison participants were 37 healthy individuals who were matched in terms of demographics and intelligence with the patient group. PM functions and clinical symptoms were measured at baseline, the sixth month, and the twelfth month, using a computerized PM task and the Positive and Negative Syndrome Scale. RESULTS:People with schizophrenia showed a gradual improvement in both time- and event-based PM 12 months after illness onset. However, compared to event-based PM, deficit in time-based PM persisted and was relatively stable. At baseline, PM functions were not associated with clinical symptoms. However, an association between time-based PM and PANSS positive and general symptoms emerged 12 months after the onset of schizophrenia. CONCLUSION:People with first-episode schizophrenia exhibit persistent time-based PM deficit. Our findings support that PM deficit, in particular, time-based deficit, may be a putative neuropsychological marker of schizophrenia.

journal_name

Schizophr Res

journal_title

Schizophrenia research

authors

Cheung EFC,Lui SSY,Wang Y,Yang TX,Shum DHK,Chan RCK

doi

10.1016/j.schres.2015.09.015

subject

Has Abstract

pub_date

2015-12-01 00:00:00

pages

147-152

issue

1-3

eissn

0920-9964

issn

1573-2509

pii

S0920-9964(15)00485-5

journal_volume

169

pub_type

杂志文章
  • Longitudinal course of self-labeling, stigma stress and well-being among young people at risk of psychosis.

    abstract::Stigma may undermine the well-being of young people at risk of psychosis. We therefore measured self-labeling, stigma variables and well-being at baseline and again one year later among 77 at-risk participants. An increase in self-labeling during this period predicted heightened stigma stress after one year and a decr...

    journal_title:Schizophrenia research

    pub_type: 杂志文章

    doi:10.1016/j.schres.2014.07.016

    authors: Rüsch N,Müller M,Heekeren K,Theodoridou A,Metzler S,Dvorsky D,Corrigan PW,Walitza S,Rössler W

    更新日期:2014-09-01 00:00:00

  • N-methyl-d-aspartate-type glutamate receptor modulators and related medications for the enhancement of auditory system plasticity in schizophrenia.

    abstract::Deficits in N-methyl-d-aspartate-type (NMDAR) function contribute to cognitive deficits in schizophrenia, particularly dysfunction in neuroplasticity, defined as reduced learning during training on exercises that place implicit, increasing demands on early sensory (auditory and visual) information processing. Auditory...

    journal_title:Schizophrenia research

    pub_type: 杂志文章,评审

    doi:10.1016/j.schres.2018.02.003

    authors: Kantrowitz JT

    更新日期:2019-05-01 00:00:00

  • Cognitive remediation therapy (CRT) for young early onset patients with schizophrenia: an exploratory randomized controlled trial.

    abstract:BACKGROUND:Schizophrenia with an onset in adolescence is known to be associated with a poorer outcome and cognitive difficulties. These impairments have an impact on quality of life and represent treatment targets. Cognitive remediation therapy (CRT) attempts to improve cognitive deficits by teaching information proces...

    journal_title:Schizophrenia research

    pub_type: 杂志文章,随机对照试验

    doi:10.1016/j.schres.2007.03.030

    authors: Wykes T,Newton E,Landau S,Rice C,Thompson N,Frangou S

    更新日期:2007-08-01 00:00:00

  • The relationship between prepulse inhibition and general psychopathology in patients with schizophrenia treated with long-acting risperidone.

    abstract::Patients with schizophrenia exhibit impairments in prepulse inhibition (PPI) of the startle response. Available data suggest that atypical antipsychotics may be more effective than typical antipsychotics in improving PPI deficits in schizophrenia. However, previous studies have used between-subjects rather than longit...

    journal_title:Schizophrenia research

    pub_type: 杂志文章

    doi:10.1016/j.schres.2009.09.035

    authors: Martinez-Gras I,Rubio G,del Manzano BA,Rodriguez-Jimenez R,Garcia-Sanchez F,Bagney A,Leza JC,Borrell J

    更新日期:2009-12-01 00:00:00

  • Grey matter networks in people at increased familial risk for schizophrenia.

    abstract::Grey matter brain networks are disrupted in schizophrenia, but it is still unclear at which point during the development of the illness these disruptions arise and whether these can be associated with behavioural predictors of schizophrenia. We investigated if single-subject grey matter networks were disrupted in a sa...

    journal_title:Schizophrenia research

    pub_type: 杂志文章

    doi:10.1016/j.schres.2015.08.025

    authors: Tijms BM,Sprooten E,Job D,Johnstone EC,Owens DG,Willshaw D,Seriès P,Lawrie SM

    更新日期:2015-10-01 00:00:00

  • A multicenter, randomized, double-blind, controlled phase 3 trial of fixed-dose brexpiprazole for the treatment of adults with acute schizophrenia.

    abstract::The objective of this study was to evaluate the efficacy, safety and tolerability of brexpiprazole versus placebo in adults with acute schizophrenia. This was a 6-week, multicenter, placebo-controlled double-blind phase 3 study. Patients with acute schizophrenia were randomized to brexpiprazole 1, 2 or 4 mg, or placeb...

    journal_title:Schizophrenia research

    pub_type: 杂志文章,多中心研究,随机对照试验

    doi:10.1016/j.schres.2015.01.038

    authors: Kane JM,Skuban A,Ouyang J,Hobart M,Pfister S,McQuade RD,Nyilas M,Carson WH,Sanchez R,Eriksson H

    更新日期:2015-05-01 00:00:00

  • Prodromal interventions for schizophrenia vulnerability: the risks of being "at risk".

    abstract::Given the morbidity and difficulty of treating psychotic disorders, including schizophrenia, there has been a move toward identifying and treating adolescents and young adults who appear to be clinically at risk or "prodromal" to psychosis. The field now has greater specificity in identification, with rates of 40-50% ...

    journal_title:Schizophrenia research

    pub_type: 杂志文章

    doi:10.1016/j.schres.2004.05.021

    authors: Corcoran C,Malaspina D,Hercher L

    更新日期:2005-03-01 00:00:00

  • Dopamine and norepinephrine activity in schizophrenia. An integrative perspective.

    abstract::The dopamine (DA) hypothesis of schizophrenia stated that increased DA activity is the primary cause of schizophrenia. Recently, even though increased DA activity is in fact involved in psychotic symptoms and antipsychotic drug response, it has become clear that decreased DA activity is present in remitted and chronic...

    journal_title:Schizophrenia research

    pub_type: 杂志文章,评审

    doi:10.1016/0920-9964(91)90032-m

    authors: van Kammen DP,Kelley M

    更新日期:1991-03-01 00:00:00

  • No evidence for structural brain changes in young adolescents at ultra high risk for psychosis.

    abstract:OBJECTIVE:The onset of psychosis is thought to be preceded by neurodevelopmental changes in the brain. However, the timing of these changes has not been established. We investigated structural brain changes in a sample of young adolescents (12-18 years) at ultra high-risk for psychosis (UHR). METHODS:Structural MRI da...

    journal_title:Schizophrenia research

    pub_type: 杂志文章

    doi:10.1016/j.schres.2009.04.013

    authors: Ziermans TB,Durston S,Sprong M,Nederveen H,van Haren NE,Schnack HG,Lahuis BE,Schothorst PF,van Engeland H

    更新日期:2009-07-01 00:00:00

  • Psychiatric treatment following participation in the CapOpus randomized trial for patients with comorbid cannabis use disorder and psychosis.

    abstract:BACKGROUND:Randomized trials targeting cannabis use disorders in patients with psychosis have generally been unsuccessful. One of the largest such trials was the CapOpus trial, which had an impact on the number of monthly joints used, but not on the number of days with cannabis use or positive or negative symptoms. OB...

    journal_title:Schizophrenia research

    pub_type: 杂志文章,随机对照试验

    doi:10.1016/j.schres.2013.10.014

    authors: Hjorthøj CR,Orlovska S,Fohlmann A,Nordentoft M

    更新日期:2013-12-01 00:00:00

  • Comparative efficacy between clozapine and other atypical antipsychotics on depressive symptoms in patients with schizophrenia: analysis of the CATIE phase 2E data.

    abstract:BACKGROUND:The comparative antidepressant effects of clozapine and other atypical antipsychotics for schizophrenia remain elusive, leading us to examine this question using the data from the Clinical Antipsychotic Trials of Intervention Effectiveness phase 2E. METHODS:Ninety-nine patients who discontinued treatment wi...

    journal_title:Schizophrenia research

    pub_type: 杂志文章,随机对照试验

    doi:10.1016/j.schres.2014.12.024

    authors: Nakajima S,Takeuchi H,Fervaha G,Plitman E,Chung JK,Caravaggio F,Iwata Y,Mihashi Y,Gerretsen P,Remington G,Mulsant B,Graff-Guerrero A

    更新日期:2015-02-01 00:00:00

  • Insular cortex gray matter changes in individuals at ultra-high-risk of developing psychosis.

    abstract::Morphologic abnormalities of the insular cortex have been described in psychotic disorders such as schizophrenia, but it remains unclear whether these changes predate the onset of psychosis or develop progressively over the course of illness. In this study, we used magnetic resonance imaging to investigate the gray ma...

    journal_title:Schizophrenia research

    pub_type: 杂志文章

    doi:10.1016/j.schres.2009.03.024

    authors: Takahashi T,Wood SJ,Yung AR,Phillips LJ,Soulsby B,McGorry PD,Tanino R,Zhou SY,Suzuki M,Velakoulis D,Pantelis C

    更新日期:2009-06-01 00:00:00

  • The factor structure and clinical utility of formal thought disorder in first episode psychosis.

    abstract:BACKGROUND:Formal thought disorder (FTD) is a core feature of psychosis, however there are gaps in our knowledge about its prevalence and factor structure. We had two aims: first, to establish the factor structure of FTD; second, to explore the clinical utility of dimensions of FTD in order to further the understanding...

    journal_title:Schizophrenia research

    pub_type: 杂志文章

    doi:10.1016/j.schres.2015.07.049

    authors: Roche E,Lyne JP,O'Donoghue B,Segurado R,Kinsella A,Hannigan A,Kelly BD,Malone K,Clarke M

    更新日期:2015-10-01 00:00:00

  • Overview of short- and long-term tolerability and safety of brexpiprazole in patients with schizophrenia.

    abstract::Second-generation antipsychotics have demonstrated efficacy for patients with schizophrenia but are associated with wide-ranging side effects. Brexpiprazole, a serotonin-dopamine activity modulator, has demonstrated efficacy in adult patients with schizophrenia. This paper provides an overview of the safety and tolera...

    journal_title:Schizophrenia research

    pub_type: 杂志文章,meta分析,评审

    doi:10.1016/j.schres.2016.04.013

    authors: Kane JM,Skuban A,Hobart M,Ouyang J,Weiller E,Weiss C,Correll CU

    更新日期:2016-07-01 00:00:00

  • Epigenetic dysregulation of HTR2A in the brain of patients with schizophrenia and bipolar disorder.

    abstract:INTRODUCTION:HTR2A gene has been the subject of numerous studies in psychiatric genetics because LSD, which resembles serotonin causes psychosis and atypical antipsychotic drugs target the HTR2A receptor. However, evidence for the role of HTR2A polymorphism(s) in schizophrenia (SCZ) and bipolar disorder (BD) has been e...

    journal_title:Schizophrenia research

    pub_type: 杂志文章

    doi:10.1016/j.schres.2011.04.007

    authors: Abdolmaleky HM,Yaqubi S,Papageorgis P,Lambert AW,Ozturk S,Sivaraman V,Thiagalingam S

    更新日期:2011-07-01 00:00:00

  • Amoxapine shows atypical antipsychotic effects in patients with schizophrenia: results from a prospective open-label study.

    abstract:OBJECTIVE:Amoxapine is marketed as an antidepressant. However, its receptor occupancy, in vitro and in vivo, and its effects in pre-clinical models are very similar to atypical antipsychotics. To examine if this leads to an atypical antipsychotic effect in the clinical context, the authors examined the antipsychotic an...

    journal_title:Schizophrenia research

    pub_type: 临床试验,杂志文章

    doi:10.1016/s0920-9964(01)00342-5

    authors: Apiquian R,Ulloa E,Fresan A,Loyzaga C,Nicolini H,Kapur S

    更新日期:2003-01-01 00:00:00

  • Therapeutic intervention for internalized stigma of severe mental illness: A systematic review and meta-analysis.

    abstract:OBJECTIVE:Internalized stigma can lead to pervasive negative effects among people with severe mental illness (SMI). Although prevalence of internalized stigma is high, there is a dearth of interventions and meanwhile a lack of evidence as to their effectiveness. This study aims at unraveling the existence of different ...

    journal_title:Schizophrenia research

    pub_type: 杂志文章,meta分析,评审

    doi:10.1016/j.schres.2016.02.013

    authors: Tsang HW,Ching SC,Tang KH,Lam HT,Law PY,Wan CN

    更新日期:2016-05-01 00:00:00

  • Somatosensory evoked potentials during a rubber-hand illusion in schizophrenia.

    abstract::The rubber-hand illusion (RHI), an illusion in which tactile sensations are referred to a synthetic alien limb, is enhanced in schizophrenia patients. Somatosensory evoked responses of the illusion were compared between schizophrenia patients and normal control subjects. Schizophrenia patients had significant alterati...

    journal_title:Schizophrenia research

    pub_type: 杂志文章

    doi:10.1016/s0920-9964(03)00057-4

    authors: Peled A,Pressman A,Geva AB,Modai I

    更新日期:2003-11-15 00:00:00

  • Early life stress and PTSD symptoms in patients with comorbid schizophrenia and substance abuse.

    abstract:OBJECTIVE:The comorbidity of schizophrenia and substance abuse is well documented and is remarkable for its prevalence and poor prognosis. While the etiology for this association is unknown, one possible mechanism relates to traumatic early life experiences, which have been shown to predispose individuals to both psych...

    journal_title:Schizophrenia research

    pub_type: 杂志文章

    doi:10.1016/s0920-9964(03)00188-9

    authors: Scheller-Gilkey G,Moynes K,Cooper I,Kant C,Miller AH

    更新日期:2004-08-01 00:00:00

  • Dissociable contributions of MRI volume reductions of superior temporal and fusiform gyri to symptoms and neuropsychology in schizophrenia.

    abstract::We sought to identify the functional correlates of reduced magnetic resonance imaging (MRI) volumes of the superior temporal gyrus (STG) and the fusiform gyrus (FG) in patients with chronic schizophrenia. MRI volumes, positive/negative symptoms, and neuropsychological tests of facial memory and executive functioning w...

    journal_title:Schizophrenia research

    pub_type: 杂志文章

    doi:10.1016/j.schres.2006.11.025

    authors: Nestor PG,Onitsuka T,Gurrera RJ,Niznikiewicz M,Frumin M,Shenton ME,McCarley RW

    更新日期:2007-03-01 00:00:00

  • Larger putamen size in antipsychotic-naïve individuals with schizotypal personality disorder.

    abstract:OBJECTIVE:To (a) compare the size of the dorsal and ventral striatum (caudate and putamen) in a large sample of antipsychotic-naïve individuals with schizotypal personality disorder (SPD) and healthy control participants; (b) examine symptom correlates of striatal size in SPD. METHODS:The left and right caudate and pu...

    journal_title:Schizophrenia research

    pub_type: 杂志文章

    doi:10.1016/j.schres.2012.11.003

    authors: Chemerinski E,Byne W,Kolaitis JC,Glanton CF,Canfield EL,Newmark RE,Haznedar MM,Novakovic V,Chu KW,Siever LJ,Hazlett EA

    更新日期:2013-01-01 00:00:00

  • The relationship between clinical and biochemical changes following neuroleptic treatment in schizophrenia.

    abstract::Clinical improvement in psychotic symptoms is not immediate when neuroleptic treatment is commenced. Previous studies have demonstrated the development of biochemical tolerance to the effects of neuroleptics on the dopamine system. This study demonstrates a relationship between this biochemical change and the clinical...

    journal_title:Schizophrenia research

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1016/0920-9964(90)90007-t

    authors: Cooper SJ,Leahey W,Liddle J,King DJ

    更新日期:1990-07-01 00:00:00

  • Changing incidence of psychotic disorders among the young in Zurich.

    abstract::There is controversy over whether the incidence rates of schizophrenia and psychotic disorders have changed in recent decades. To detect deviations from trends in incidence, we analysed admission data of patients with an ICD-8/9/10 diagnosis of psychotic disorders in the Canton Zurich / Switzerland, for the period 197...

    journal_title:Schizophrenia research

    pub_type: 杂志文章

    doi:10.1016/j.schres.2007.06.001

    authors: Ajdacic-Gross V,Lauber C,Warnke I,Haker H,Murray RM,Rössler W

    更新日期:2007-09-01 00:00:00

  • Resequencing of the vesicular glutamate transporter 2 gene (VGLUT2) reveals some rare genetic variants that may increase the genetic burden in schizophrenia.

    abstract:OBJECTIVES:Vesicular glutamate transporters (VGLUT1-3) package glutamate into vesicles in the presynaptic terminal and regulate the release of glutamate. In mesencephalic dopamine neuron culture, the majority of isolated dopamine neurons express VGLUT2, but not VGLUT1 or 3, have been demonstrated. As related to the dys...

    journal_title:Schizophrenia research

    pub_type: 杂志文章

    doi:10.1016/j.schres.2010.05.015

    authors: Shen YC,Liao DL,Lu CL,Chen JY,Liou YJ,Chen TT,Chen CH

    更新日期:2010-08-01 00:00:00

  • Abnormal white matter microstructure in schizophrenia: a voxelwise analysis of axial and radial diffusivity.

    abstract::Diffusion Tensor Imaging (DTI) investigations in schizophrenia have provided evidence of impairment in white matter as indicated by reduced fractional anisotropy (FA). However, the neuropathological implications of these findings remain unclear. In the current study, we conducted a voxelwise analysis of the constituen...

    journal_title:Schizophrenia research

    pub_type: 杂志文章

    doi:10.1016/j.schres.2007.12.489

    authors: Seal ML,Yücel M,Fornito A,Wood SJ,Harrison BJ,Walterfang M,Pell GS,Pantelis C

    更新日期:2008-04-01 00:00:00

  • Social cognition and quality of life in schizophrenia.

    abstract::Schizophrenia is associated with poor quality of life (QOL). Whereas the effects of neurocognitive deficits and psychopathology on QOL of schizophrenia patients have recently been elucidated, little is known about social cognitive deficits in this regard. This study investigated the influence of social cognition on QO...

    journal_title:Schizophrenia research

    pub_type: 杂志文章,多中心研究

    doi:10.1016/j.schres.2012.02.017

    authors: Maat A,Fett AK,Derks E,GROUP Investigators.

    更新日期:2012-05-01 00:00:00

  • Differential patterns of premorbid social and academic deterioration in deficit and nondeficit schizophrenia.

    abstract::Numerous studies indicate that social dysfunction is associated with negative symptoms of schizophrenia during the chronic phase of illness. However, it is unclear whether social abnormalities exist during the premorbid phase in people who later develop schizophrenia with prominent negative symptoms, or whether social...

    journal_title:Schizophrenia research

    pub_type: 杂志文章

    doi:10.1016/j.schres.2011.11.007

    authors: Strauss GP,Allen DN,Miski P,Buchanan RW,Kirkpatrick B,Carpenter WT Jr

    更新日期:2012-03-01 00:00:00

  • A comparative study of sertraline versus imipramine in postpsychotic depressive disorder of schizophrenia.

    abstract::The objective of this study was to compare the efficacy and reliability of sertraline versus imipramine in the treatment of postpsychotic depressive disorder of schizophrenia. The diagnosis was based on DSM-IV research criteria. The Sympson-Angus Scale and SANS were performed in order to discriminate between depressiv...

    journal_title:Schizophrenia research

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1016/s0920-9964(98)00054-1

    authors: Kirli S,Caliskan M

    更新日期:1998-09-07 00:00:00

  • Impaired cognitive control mediates the relationship between cortical thickness of the superior frontal gyrus and role functioning in schizophrenia.

    abstract::Structural abnormalities in the lateral prefrontal cortex (LPFC) are well-documented in schizophrenia and recent evidence suggests that these abnormalities relate to functional outcome. Cognitive control mechanisms, reliant on the LPFC, are impaired in schizophrenia and predict functional outcome, thus impaired cognit...

    journal_title:Schizophrenia research

    pub_type: 杂志文章

    doi:10.1016/j.schres.2013.12.005

    authors: Tully LM,Lincoln SH,Liyanage-Don N,Hooker CI

    更新日期:2014-02-01 00:00:00

  • Ketogenic diet prevents impaired prepulse inhibition of startle in an acute NMDA receptor hypofunction model of schizophrenia.

    abstract::Recent transcriptomic, proteomic and metabolomics studies have highlighted an abnormal cerebral glucose and energy metabolism as one of the potential pathophysiological mechanisms of schizophrenia. This raises the possibility that a metabolically-based intervention might have therapeutic value in the management of sch...

    journal_title:Schizophrenia research

    pub_type: 杂志文章

    doi:10.1016/j.schres.2018.11.011

    authors: Kraeuter AK,van den Buuse M,Sarnyai Z

    更新日期:2019-04-01 00:00:00